A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathies

Joint Bone Spine

Volumn 76, Issue 2, 2009, Pages 123-125

  Goupille, Philippe ^a   Pham, Thao ^b   Claudepierre, Pascal ^c   Wendling, Daniel ^d  

^a UNIVERSITÉ DE TOURS   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Diagnosis; Magnetic resonance imaging; Spondyloarthropathies; Treatment

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; SACROILIAC JOINT; SPINE; SPONDYLOARTHROPATHY;

ANTIRHEUMATIC AGENTS; CASE MANAGEMENT; HUMANS; MAGNETIC RESONANCE IMAGING; SACROILIAC JOINT; SPINE; SPONDYLARTHROPATHIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61649122785     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.12.001     Document Type: Editorial

References (24)

1. Wendling D. Ankylosing spondylitis without radiological sacroiliitis: a (re)current problem. Joint Bone Spine 73 (2006) 584-586
2. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of the diagnostic criteria for ankylosing spondylitis. A proposal for modifications of the New York criteria. Arthritis Rheum 27 (1984) 361-368
3. Mau W., Zeidler H., Mau R., et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up. J Rheumatol 15 (1988) 1109-1114
4. Amor B., Dougados M., Listrat V., et al. Are classification criteria for spondylarthropathy useful as diagnostic criteria?. Rev Rhum Engl Ed 62 (1995) 10-15
5. Dougados M., van der Linden S., Juhlin R., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34 (1991) 1218-1227
6. Zochling J., van der Heijde D., Dougados M., et al. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 65 (2006) 423-432
7. van der Heijde D., Kivitz A., Schiff M.H., et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis. Results of a multicenter, randomised, double-blind, placebo-controlled trial. Arthritis Rheum 54 (2006) 2136-2146
8. Braun J., Davis J., Dougados M., et al., for the ASAS working group. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65 (2006) 316-320
9. Pham T., Guillemin F., Claudepierre P., et al. Recommendations of the French Society for Rheumatology for the use of anti-TNF alpha agents in ankylosing spondylitis and psoriatic arthritis. Joint Bone Spine 73 (2006) 433-441
10. Pham T., Fautrel B., Dernis E., et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 74 (2007) 638-646
11. Oostveen J., Prevo R., den Boer J., et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective longitudinal study. J Rheumatol 26 (1999) 1953-1958
12. Wendling D., Toussirot E., Streit G., et al. Imaging study scores for ankylosing spondylitis. Joint Bone Spine 73 (2006) 655-660
13. Baraliakos X., and Braun J. Magnetic resonance imaging in spondyloarthropathies. Joint Bone Spine 73 (2006) 1-3
14. Haibel H., Rudwaleit M., Listing J., et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 58 (2008) 1981-1991
15. Barkham N, Keen H, Coates L, et al. A randomized controlled trial of infliximab shows clinical and MRI efficacy in patients with HLA B27 positive very early ankylosing spondylitis. 2007 Annual scientific meeting of the American College of Rheumatology, Boston, November 6-11, 2007 (Late-breaking abstract 11).
16. den Broeder A.A., Reijnierse M., Crombag A.C., et al. Diagnostic characteristics of MRI in suspected SPA in clinical practice: high inter-reader agreement but limited additional value of gadolinium contrast. Ann Rheum Dis 67 Suppl. II (2008) 383 (Abstract FRI0313)
17. Goupille P., Cotty P., Mulleman D., et al. Magnetic resonance imaging for the diagnosis of ankylosing spondylitis: performed on the spine, sacroiliac joints, or both? Annual European Congress of Rheumatology, Paris, 11-14 June 2008. Ann Rheum Dis 67 Suppl. II (2008) 386 (Abstract FRI0324)
18. Bennett A.N., Rehman A., Hensor E., et al. The diagnostic utility of MRI in spondylarthropathy. Arthritis Rheum 58 Suppl. 9 (2008) S354 (Abstract 510)
19. Weber U., Hodler J., Lambert R., et al. Sensitivity and specificity of spinal inflammatory lesions assessed by whole body MRI in patients with spondyloarthritis and recent-onset inflammatory back pain. Arthritis Rheum 58 Suppl. 9 (2008) S888 (Abstract 1968)
20. Weber U., Maksymowych W.P., Jurik A.G., et al. Validation of whole body MRI against conventional MRI for scoring inflammatory lesions in the sacroiliac joints of patients with spondyloarthritis. Arthritis Rheum 58 Suppl. 9 (2008) S699 (Abstract 1436)
21. Weber U., Hodler J., Jurik A.G., et al. Validation of whole body MRI against conventional MRI for assessing inflammatory changes of the entire spine in spondyloarthritis. Arthritis Rheum 58 Suppl. 9 (2008) S905 (Abstract 2012)
22. Bennett A.N., McGonagle D., O'Connor P., et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58 (2008) 3413-3418
23. Rudwaleit M., Schwarzlose S., Hilgert E.S., et al. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67 (2008) 1276-1281
24. Griffoul I., Giraudeau B., Mulleman D., et al. Infliximab for treating axial spondylarthropathy in everyday practice. Joint Bone Spine (2008) Dec 6 [Epub ahead of print]